HK1126397A1 - External preparation for skin containing flavanone derivative - Google Patents

External preparation for skin containing flavanone derivative

Info

Publication number
HK1126397A1
HK1126397A1 HK09104831.6A HK09104831A HK1126397A1 HK 1126397 A1 HK1126397 A1 HK 1126397A1 HK 09104831 A HK09104831 A HK 09104831A HK 1126397 A1 HK1126397 A1 HK 1126397A1
Authority
HK
Hong Kong
Prior art keywords
external preparation
skin containing
flavanone derivative
containing flavanone
derivative
Prior art date
Application number
HK09104831.6A
Other languages
English (en)
Inventor
Naoko Kida
Akihiro Tada
Akiko Kanamaru
Original Assignee
Pola Chem Ind Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chem Ind Inc filed Critical Pola Chem Ind Inc
Publication of HK1126397A1 publication Critical patent/HK1126397A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/38—Clusiaceae, Hypericaceae or Guttiferae (Hypericum or Mangosteen family), e.g. common St. Johnswort
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Hematology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Birds (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • General Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
HK09104831.6A 2006-02-15 2009-05-27 External preparation for skin containing flavanone derivative HK1126397A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2006037647 2006-02-15
JP2006181185 2006-06-30
JP2006181186 2006-06-30
JP2006195034 2006-07-18
PCT/JP2007/052672 WO2007094384A1 (ja) 2006-02-15 2007-02-15 フラバノン誘導体を含む皮膚外用剤

Publications (1)

Publication Number Publication Date
HK1126397A1 true HK1126397A1 (en) 2009-09-04

Family

ID=38371563

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09104831.6A HK1126397A1 (en) 2006-02-15 2009-05-27 External preparation for skin containing flavanone derivative

Country Status (11)

Country Link
US (2) US20090030070A1 (de)
EP (1) EP1987810B1 (de)
JP (1) JP5124440B2 (de)
KR (1) KR101329936B1 (de)
CN (1) CN101384246B (de)
AU (1) AU2007215822B2 (de)
CA (1) CA2642524C (de)
HK (1) HK1126397A1 (de)
MY (1) MY154397A (de)
SG (1) SG169995A1 (de)
WO (1) WO2007094384A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8298584B2 (en) * 2008-12-30 2012-10-30 Collagen Matrix, Inc. Biopolymeric membrane for wound protection and repair
JP2010215532A (ja) * 2009-03-13 2010-09-30 Ands Corporation コラーゲンゲル収縮促進剤
MX2011010609A (es) * 2009-04-07 2011-12-16 Holland Colours Nv Concentrado de aditivo para polimeros.
WO2012091832A2 (en) * 2010-12-30 2012-07-05 Avon Products, Inc. Modulation of dynein in skin
CN103012348B (zh) * 2012-12-19 2015-04-08 苏薇薇 一种6,8位取代柚皮素衍生物及其应用
CN104758190B (zh) * 2014-01-03 2018-04-20 伽蓝（集团）股份有限公司 一种含有二氢黄酮类衍生物的皮肤外用剂组合物
CN104758191A (zh) * 2014-01-07 2015-07-08 香港大学 抑制黑色素合成的组合物
KR101965032B1 (ko) * 2016-05-25 2019-04-02 경북대학교 산학협력단 물레나물 추출물을 포함하는 화장료 조성물
CN115364039B (zh) * 2022-09-28 2023-07-25 佛山天韵化妆品科技有限公司 一种痤疮皮肤修复组合物及其应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7000180A (de) * 1969-01-10 1970-07-14
US5288485A (en) * 1989-08-31 1994-02-22 Kao Corporation Vasodilating agent
NZ299379A (en) * 1995-10-27 1997-04-24 Unilever Plc Topical flavanone-containing composition
US5665367A (en) * 1996-09-27 1997-09-09 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Skin care compositions containing naringenin and/or quercetin and a retinoid
JPH11315008A (ja) * 1998-03-03 1999-11-16 Shiseido Co Ltd 抗老化剤
EP1104672A1 (de) * 1999-12-02 2001-06-06 Laboratoires Serobiologiques(Societe Anonyme) Kosmetische und/oder pharmazeutische Zubereitungen
JP2002029986A (ja) * 2000-07-19 2002-01-29 Pola Chem Ind Inc 真皮コラーゲン線維束再構築剤及びそれを含有する組成物
US20030125264A1 (en) * 2001-12-29 2003-07-03 Kimberly-Clark Worldwide, Inc. Methods For Treating Wounds
JP4801563B2 (ja) * 2006-11-06 2011-10-26 ポーラ化成工業株式会社 乳化剤形の化粧料

Also Published As

Publication number Publication date
EP1987810B1 (de) 2017-06-07
CN101384246B (zh) 2012-01-04
KR101329936B1 (ko) 2013-11-14
MY154397A (en) 2015-06-15
AU2007215822B2 (en) 2012-10-25
JPWO2007094384A1 (ja) 2009-07-09
CA2642524A1 (en) 2007-08-23
US20110021619A1 (en) 2011-01-27
WO2007094384A1 (ja) 2007-08-23
KR20080094950A (ko) 2008-10-27
CN101384246A (zh) 2009-03-11
SG169995A1 (en) 2011-04-29
EP1987810A1 (de) 2008-11-05
AU2007215822A1 (en) 2007-08-23
JP5124440B2 (ja) 2013-01-23
CA2642524C (en) 2015-10-13
US20090030070A1 (en) 2009-01-29
EP1987810A4 (de) 2014-12-24

Similar Documents

Publication Publication Date Title
EP2027849A4 (de) Topisches hautpräparat
IL186871A0 (en) External preparation for skin
HK1122991A1 (en) External preparation for skin
IL194367A0 (en) Dihydropyrazolopyrimidinone derivatives
IL196543A0 (en) Pyridizinone derivatives
IL193641A0 (en) Spiroindolinone derivatives
IL195013A0 (en) Pyridopyrimidinone derivatives
GB2458228B (en) External preparation for skin
EP1973405A4 (de) Hydroxyalkylarylamid-derivate
IL198319A0 (en) Spiroindolinone derivatives
IL195422A0 (en) 2-pyrazinecarboxamide derivatives
HK1126397A1 (en) External preparation for skin containing flavanone derivative
IL195287A0 (en) 2-thioxanthine derivatives acting as mpo-inhibitors
IL192401A0 (en) Indol-3-yl-carbonyl-spiro-piperidine derivatives
IL198059A0 (en) 2-aminocarbonyl-pyridine derivatives
IL196364A0 (en) Aminoindazolylurea derivatives
HK1136276A1 (en) 5-hydroxymethyl-oxazolidin-2-one derivatives 5---2-
IL193211A0 (en) Indazole-heteroaryl derivatives
IL197152A0 (en) 5-phenyl-nicotinamide derivatives
EP2043633A4 (de) Thiadiazolidinonderivate
ZA200901034B (en) Avermectin derivatives
IL197239A0 (en) Phenyloxyaniline derivatives
ZA200807460B (en) Spiroindolinone derivatives
GB0604905D0 (en) Pyrone Derivatives
GB0624214D0 (en) Benzotriazepinone derivatives